 | • レポートコード：MRC309Z7871 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のグアンファシンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のグアンファシン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - グアンファシンの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため グアンファシン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・グアンファシン徐放丸薬、グアンファシン錠、その他 用途別セグメント ・高血圧治療、ADHD治療、その他 主要な市場プレーヤー ・Teva、TWi Pharmaceuticals、Aurobindo Pharma、Quimica Sintetica Sa、Apotex、Medichem、Shire Pharmaceuticals、Jubilant Pharmova、Viatris、Epic Pharma、Procos Spa 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、グアンファシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なグアンファシンメーカーの企業概要、2019年～2022年までのグアンファシンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なグアンファシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別グアンファシンの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのグアンファシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのグアンファシン市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびグアンファシンの産業チェーンを掲載しています。 ・第14、15章では、グアンファシンの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - グアンファシンの概要 - 種類別分析（2018年vs2022年vs2029年）：グアンファシン徐放丸薬、グアンファシン錠、その他 - 用途別分析（2018年vs2022年vs2029年）：高血圧治療、ADHD治療、その他 - 世界のグアンファシン市場規模・予測 - 世界のグアンファシン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Teva、TWi Pharmaceuticals、Aurobindo Pharma、Quimica Sintetica Sa、Apotex、Medichem、Shire Pharmaceuticals、Jubilant Pharmova、Viatris、Epic Pharma、Procos Spa ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：グアンファシン徐放丸薬、グアンファシン錠、その他 ・用途別分析2018年-2029年：高血圧治療、ADHD治療、その他 ・グアンファシンの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・グアンファシンのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・グアンファシンのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・グアンファシンの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・グアンファシンの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Guanfacine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Guanfacine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Guanfacine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Guanfacine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Guanfacine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Guanfacine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Guanfacine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Guanfacine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, TWi Pharmaceuticals, Aurobindo Pharma, Quimica Sintetica Sa and Apotex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Guanfacine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Guanfacine Sustained-Release Pills
Guanfacine Tablets
Other
Market segment by Application
Treatment Of High Blood Pressure
Treatment Of ADHD
Other
Major players covered
Teva
TWi Pharmaceuticals
Aurobindo Pharma
Quimica Sintetica Sa
Apotex
Medichem
Shire Pharmaceuticals
Jubilant Pharmova
Viatris
Epic Pharma
Procos Spa
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Guanfacine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Guanfacine, with price, sales, revenue and global market share of Guanfacine from 2018 to 2023.
Chapter 3, the Guanfacine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Guanfacine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Guanfacine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Guanfacine.
Chapter 14 and 15, to describe Guanfacine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Guanfacine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Guanfacine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Guanfacine Sustained-Release Pills
1.3.3 Guanfacine Tablets
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Guanfacine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Treatment Of High Blood Pressure
1.4.3 Treatment Of ADHD
1.4.4 Other
1.5 Global Guanfacine Market Size & Forecast
1.5.1 Global Guanfacine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Guanfacine Sales Quantity (2018-2029)
1.5.3 Global Guanfacine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Guanfacine Product and Services
2.1.4 Teva Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Recent Developments/Updates
2.2 TWi Pharmaceuticals
2.2.1 TWi Pharmaceuticals Details
2.2.2 TWi Pharmaceuticals Major Business
2.2.3 TWi Pharmaceuticals Guanfacine Product and Services
2.2.4 TWi Pharmaceuticals Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 TWi Pharmaceuticals Recent Developments/Updates
2.3 Aurobindo Pharma
2.3.1 Aurobindo Pharma Details
2.3.2 Aurobindo Pharma Major Business
2.3.3 Aurobindo Pharma Guanfacine Product and Services
2.3.4 Aurobindo Pharma Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Aurobindo Pharma Recent Developments/Updates
2.4 Quimica Sintetica Sa
2.4.1 Quimica Sintetica Sa Details
2.4.2 Quimica Sintetica Sa Major Business
2.4.3 Quimica Sintetica Sa Guanfacine Product and Services
2.4.4 Quimica Sintetica Sa Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Quimica Sintetica Sa Recent Developments/Updates
2.5 Apotex
2.5.1 Apotex Details
2.5.2 Apotex Major Business
2.5.3 Apotex Guanfacine Product and Services
2.5.4 Apotex Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Apotex Recent Developments/Updates
2.6 Medichem
2.6.1 Medichem Details
2.6.2 Medichem Major Business
2.6.3 Medichem Guanfacine Product and Services
2.6.4 Medichem Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Medichem Recent Developments/Updates
2.7 Shire Pharmaceuticals
2.7.1 Shire Pharmaceuticals Details
2.7.2 Shire Pharmaceuticals Major Business
2.7.3 Shire Pharmaceuticals Guanfacine Product and Services
2.7.4 Shire Pharmaceuticals Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shire Pharmaceuticals Recent Developments/Updates
2.8 Jubilant Pharmova
2.8.1 Jubilant Pharmova Details
2.8.2 Jubilant Pharmova Major Business
2.8.3 Jubilant Pharmova Guanfacine Product and Services
2.8.4 Jubilant Pharmova Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jubilant Pharmova Recent Developments/Updates
2.9 Viatris
2.9.1 Viatris Details
2.9.2 Viatris Major Business
2.9.3 Viatris Guanfacine Product and Services
2.9.4 Viatris Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Viatris Recent Developments/Updates
2.10 Epic Pharma
2.10.1 Epic Pharma Details
2.10.2 Epic Pharma Major Business
2.10.3 Epic Pharma Guanfacine Product and Services
2.10.4 Epic Pharma Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Epic Pharma Recent Developments/Updates
2.11 Procos Spa
2.11.1 Procos Spa Details
2.11.2 Procos Spa Major Business
2.11.3 Procos Spa Guanfacine Product and Services
2.11.4 Procos Spa Guanfacine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Procos Spa Recent Developments/Updates
3 Competitive Environment: Guanfacine by Manufacturer
3.1 Global Guanfacine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Guanfacine Revenue by Manufacturer (2018-2023)
3.3 Global Guanfacine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Guanfacine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Guanfacine Manufacturer Market Share in 2022
3.4.2 Top 6 Guanfacine Manufacturer Market Share in 2022
3.5 Guanfacine Market: Overall Company Footprint Analysis
3.5.1 Guanfacine Market: Region Footprint
3.5.2 Guanfacine Market: Company Product Type Footprint
3.5.3 Guanfacine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Guanfacine Market Size by Region
4.1.1 Global Guanfacine Sales Quantity by Region (2018-2029)
4.1.2 Global Guanfacine Consumption Value by Region (2018-2029)
4.1.3 Global Guanfacine Average Price by Region (2018-2029)
4.2 North America Guanfacine Consumption Value (2018-2029)
4.3 Europe Guanfacine Consumption Value (2018-2029)
4.4 Asia-Pacific Guanfacine Consumption Value (2018-2029)
4.5 South America Guanfacine Consumption Value (2018-2029)
4.6 Middle East and Africa Guanfacine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Guanfacine Sales Quantity by Type (2018-2029)
5.2 Global Guanfacine Consumption Value by Type (2018-2029)
5.3 Global Guanfacine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Guanfacine Sales Quantity by Application (2018-2029)
6.2 Global Guanfacine Consumption Value by Application (2018-2029)
6.3 Global Guanfacine Average Price by Application (2018-2029)
7 North America
7.1 North America Guanfacine Sales Quantity by Type (2018-2029)
7.2 North America Guanfacine Sales Quantity by Application (2018-2029)
7.3 North America Guanfacine Market Size by Country
7.3.1 North America Guanfacine Sales Quantity by Country (2018-2029)
7.3.2 North America Guanfacine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Guanfacine Sales Quantity by Type (2018-2029)
8.2 Europe Guanfacine Sales Quantity by Application (2018-2029)
8.3 Europe Guanfacine Market Size by Country
8.3.1 Europe Guanfacine Sales Quantity by Country (2018-2029)
8.3.2 Europe Guanfacine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Guanfacine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Guanfacine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Guanfacine Market Size by Region
9.3.1 Asia-Pacific Guanfacine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Guanfacine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Guanfacine Sales Quantity by Type (2018-2029)
10.2 South America Guanfacine Sales Quantity by Application (2018-2029)
10.3 South America Guanfacine Market Size by Country
10.3.1 South America Guanfacine Sales Quantity by Country (2018-2029)
10.3.2 South America Guanfacine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Guanfacine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Guanfacine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Guanfacine Market Size by Country
11.3.1 Middle East & Africa Guanfacine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Guanfacine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Guanfacine Market Drivers
12.2 Guanfacine Market Restraints
12.3 Guanfacine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Guanfacine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Guanfacine
13.3 Guanfacine Production Process
13.4 Guanfacine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Guanfacine Typical Distributors
14.3 Guanfacine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer